MHC class I-presented tumor antigen appraisable for T-cell responses against ovarian cancer
The purpose of this study is to assess whether MHC class I-presented tumor antigen is appraisable for T-cell responses against ovarian cancer. In ovarian cancer cell, human leukocyte antigen A2 (HLA-A2) associated with peptides was used to promote the activation of naive T cells so as to activate an...
Saved in:
Main Authors: | Jing Yao Wang (Author), Nan Zhang (Author), Xiaojie Yang (Author), Danli Gao (Author), Lirong Yin (Author), Shuying Ji (Author) |
---|---|
Format: | Book |
Published: |
Bangladesh Pharmacological Society,
2015-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune Evasion through Loss of MHC Class I Antigen Presentation
by: Annissa Ambaravista Nasution, et al.
Published: (2023) -
Loss of MHC-I antigen presentation correlated with immune checkpoint blockade tolerance in MAPK inhibitor-resistant melanoma
by: Jing Yu, et al.
Published: (2022) -
Hematopoietic Cell Transplantation for MHC Class II Deficiency
by: Su Han Lum, et al.
Published: (2019) -
Mass Spectrometry Reveals Changes in MHC I Antigen Presentation After Lentivector Expression of a Gene Regulation System
by: Roland Vogel, et al.
Published: (2013) -
Understanding the impact of ErbB activating events and signal transduction on antigen processing and presentation: MHC expression as a model
by: Anna E. Kersh, et al.
Published: (2016)